Gentronix
Gentronix provides services for the development of drugs and other chemicals in the cosmetics and personal care sectors.
Gentronix has raised €1.7M across 2 funding rounds from 2 investors, most recently a round in Nov 2021. Based in Manchester, UK; founded 1999; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.7M
€1,703,198
Funding rounds
2
Investors
2
distinct backers
Active since
2020-01
latest 2021-11
Funding by year
EUR raised per yearGentronix — funding by year — interactive chart.
Data table
| Gentronix — funding by year | |
|---|---|
| 2020 | €881k |
| 2021 | €822k |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood3
base rate 11% (2+ rounds)
- ▼ Old (27y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-11-15 | Other | €822k | Mercia’s Northern Venture Capital Trust (VCT) | View deal → |
| 2020-01-20 | Other | €881k | Mercia Asset Management | View deal → |
Related news
- Contract research firm set to double in size following GBP700k investmentprivateequitywire.co.uk · 2021-11
- finsmes.com
Similar companies
same sector or countryGlobal coverage: FundingData